Michael O’Rourke CEO presents online at the OIS Drug Delivery Forum – 5th November 2020
Michael O’Rourke CEO presents online at the Ophthalmology Futures Forums 30th September 2020
Michael O'Rourke, CEO of Re-Vana Therapeutics, presents online at the Ophthalmology Futures Forums on Wednesday, September 30th, 2020. https://youtu.be/iUBtmg7jCWo
Northern Ireland Tech 50 ranking for 2020.
Welcome to BusinessCloud’s Northern Ireland Tech 50 ranking for 2020. Cemetery software firm PlotBox tops our inaugural ranking of Northern Ireland’s most innovative technology companies. See Full Article at BusinessCloud >>
Michael O’Rourke CEO joins Ophthalmology Futures Forum Advisory Board
See the entire Opthamology Future Forum Advisory Board at: https://www.ophthalmology-futures.com/about-us/advisory-board/
Re-Vana Therapeutics Raises $3.25 Million in Pre-Series A Financing
Belfast, Northern Ireland – June 2, 2020 – Re-Vana Therapeutics Ltd, a privately-held specialty therapeutic and drug delivery company developing sustained-release therapeutics for significant sight-threatening ocular diseases, today announced that it has closed $3.25...
Michael Nash, CCO, presented Re-Vana Therapeutics at the Glaucoma 360 New Horizons Forum
… The late-morning session, titled “New Horizons in Drug Delivery,” will focus exciting innovations in drug delivery systems, with moderators Michael Robinson, MD, vice president and Therapeutic Area head, Allergan; and James C. Tsai, MD, MBA, National Eye Health...